STAT November 19, 2024
Andrew Joseph

Pharma executives at an investor conference minimized the potential impact of RFK Jr. at HHS

LONDON — Robert F. Kennedy Jr. has been a vocal critic of the pharma industry. He’s said it’s corrupted U.S. health agencies and has attacked, often with false arguments, products from vaccines to obesity medications.

So when President-elect Trump, who...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Govt Agencies, HHS, Pharma, Pharma / Biotech, Trends
Will Trump Drug Tariffs Help Or Hurt The U.S.?
Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
Walgreens To Be Acquired By PE Firm Sycamore Partners Amid Shift In Health Care Strategy
First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
Medicare Coverage Of Medical Technologies In A New Era

Share This Article